MX2023005293A - Composiciones, dispositivos y metodos de prueba de sensibilidad a la depresion. - Google Patents

Composiciones, dispositivos y metodos de prueba de sensibilidad a la depresion.

Info

Publication number
MX2023005293A
MX2023005293A MX2023005293A MX2023005293A MX2023005293A MX 2023005293 A MX2023005293 A MX 2023005293A MX 2023005293 A MX2023005293 A MX 2023005293A MX 2023005293 A MX2023005293 A MX 2023005293A MX 2023005293 A MX2023005293 A MX 2023005293A
Authority
MX
Mexico
Prior art keywords
value
methods
compositions
devices
food
Prior art date
Application number
MX2023005293A
Other languages
English (en)
Spanish (es)
Inventor
Zackary Irani-Cohen
Elisabeth Laderman
Original Assignee
Biomerica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerica Inc filed Critical Biomerica Inc
Publication of MX2023005293A publication Critical patent/MX2023005293A/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/60ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/02Nutritional disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/30Psychoses; Psychiatry
    • G01N2800/304Mood disorders, e.g. bipolar, depression

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MX2023005293A 2016-07-08 2019-01-07 Composiciones, dispositivos y metodos de prueba de sensibilidad a la depresion. MX2023005293A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662359909P 2016-07-08 2016-07-08

Publications (1)

Publication Number Publication Date
MX2023005293A true MX2023005293A (es) 2023-05-24

Family

ID=66471933

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023005293A MX2023005293A (es) 2016-07-08 2019-01-07 Composiciones, dispositivos y metodos de prueba de sensibilidad a la depresion.

Country Status (5)

Country Link
US (1) US12216127B2 (cg-RX-API-DMAC7.html)
EP (1) EP3497447B1 (cg-RX-API-DMAC7.html)
JP (3) JP6943479B2 (cg-RX-API-DMAC7.html)
CN (1) CN109804247A (cg-RX-API-DMAC7.html)
MX (1) MX2023005293A (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3940380A1 (en) 2014-11-14 2022-01-19 Biomerica Inc. Compositions, devices, and methods of ibs sensitivity testing
JP6943479B2 (ja) 2016-07-08 2021-09-29 バイオメリカ・インコーポレイテッドBiomerica, Inc. うつ病感受性試験の組成物、デバイスおよび方法
CN116832066B (zh) * 2023-08-08 2024-01-12 青岛海洋生物医药研究院股份有限公司 乌贼墨提取物在制备抗多动症和抗抑郁症药物中的应用
CN120463554B (zh) * 2025-06-05 2025-12-09 广州市南沙区万顷沙镇农业农村技术服务中心 一种番石榴专用有机肥及其制备方法

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208479A (en) 1977-07-14 1980-06-17 Syva Company Label modified immunoassays
US4963356A (en) 1982-10-13 1990-10-16 Minnesota Mining And Manufacturing Company Stable antigenic extracts methods
US4528267A (en) 1982-11-26 1985-07-09 Axionics, Inc. Fluorometirc enzyme inhibition immunoassay for measuring potency of allergen extracts
US5833976A (en) 1991-08-06 1998-11-10 Schering Corporation Use of interleukin-10 (IL-10) to treat endotoxin- or superantigen-induced toxicity
EP0556745A1 (en) * 1992-02-21 1993-08-25 Abbott Laboratories Method for detection of anti-wheat-protein antibodies
US5314804A (en) 1992-03-24 1994-05-24 Serim Research Corporation Test for Helicobacter pylori
DE69919327D1 (de) 1998-01-30 2009-11-26 Allertein Therapeutics Llc Prognostische allergie- oder entzündungstest
US6152887A (en) 1998-02-27 2000-11-28 Blume; Richard Stephen Method and test kit for oral sampling and diagnosis
ATE343793T1 (de) * 1999-05-03 2006-11-15 Evotec Ag Methode zur diagnostizierung, prognose oder evaluation von behandlung der depressionen, basiert auf erhöhte neurotrophin concentrationen in zerebrospinale flüssigkeit.
US20020002270A1 (en) 1999-06-16 2002-01-03 Raymond P. Zinkowski Purified antigen for alzheimer's disease, and methods of obtaining and using same
US6458550B1 (en) 2000-01-07 2002-10-01 Rush-Presbyterian-St. Luke's Medical Center Test for ovarian autoimmunity by detecting autoantibodies to CYP17
US6667160B2 (en) 2000-03-15 2003-12-23 Kenneth D. Fine Method for diagnosing immunologic food sensitivity
EP1195606A1 (en) * 2000-10-03 2002-04-10 VBC-Genomics Forschungsges.m.b.H. Allergen-microarray assay
US6858398B2 (en) 2001-08-14 2005-02-22 Immunosciences Lab., Inc. Saliva test for detection of food allergy and intolerance
JP4073231B2 (ja) 2002-03-28 2008-04-09 久光製薬株式会社 シ−ト状貼付剤
US20040091843A1 (en) 2002-11-12 2004-05-13 Albro Todd M. Menu generator, system and methods for generating clinical menus
GB0310522D0 (en) 2003-05-08 2003-06-11 Yorktest Lab Ltd Assay panel
US7194301B2 (en) * 2003-10-06 2007-03-20 Transneuronic, Inc. Method for screening and treating patients at risk of medical disorders
US20050137987A1 (en) 2003-12-22 2005-06-23 Robert May Customer age verification
US8309318B2 (en) 2004-02-10 2012-11-13 Brendan Bioscience, Llc Detection of antigen specific immunocomplexes
WO2005078442A1 (en) 2004-02-10 2005-08-25 Dantini Daniel C Comprehensive food allergy test
US7353080B2 (en) 2004-02-19 2008-04-01 Walker Digital, Llc Products and processes for controlling access to vending machine products
EP1804059A2 (en) 2004-05-21 2007-07-04 Atonomics A/S Surface acoustic wave sensor comprising a hydrogel
US7601509B2 (en) * 2004-07-15 2009-10-13 Power Laura W Biotype diets system: predicting food allergies by blood type
US7756604B1 (en) 2005-03-09 2010-07-13 Davis Daniel W Product control system
JP2009509124A (ja) 2005-06-16 2009-03-05 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 大型のパラレルの免疫ベースのアレルギー試験および蛍光のエバネセント場励起のためのデバイス
US20080073430A1 (en) 2006-09-22 2008-03-27 Sickenius Louis S Sense and Respond Purchase Restriction Management System
US8709413B2 (en) 2006-12-13 2014-04-29 Michael R. Simon Treatment of celiac disease with IgA
WO2008121406A1 (en) 2007-03-30 2008-10-09 Metametrix Clinical Laboratory Detection of food specific human igg4 antibodies
CN101109750A (zh) 2007-07-27 2008-01-23 杭州浙大生科生物技术有限公司 食物过敏原特异性IgG ELISA检测试剂盒及其制备方法
US20100227340A1 (en) 2007-09-10 2010-09-09 Immunohealth International, Llc Method of analysis, detection and correction of food intolerance in humans
US20140257708A1 (en) * 2008-03-04 2014-09-11 Ridge Diagnostics, Inc. Diagnosing and monitoring depression disorders
JP5658571B2 (ja) * 2008-03-12 2015-01-28 リッジ ダイアグノスティックス,インコーポレイテッド うつ障害をモニタリングするための炎症バイオマーカー
US20090253154A1 (en) 2008-04-02 2009-10-08 Immunosciences Lab., Inc. Blood and saliva test for detection of delayed food allergy and intolerance against modified foods
KR20090108968A (ko) 2008-04-14 2009-10-19 이연희 성인병 전문식당 서비스 시스템 및 그 운영방법
WO2010049726A1 (en) 2008-10-27 2010-05-06 The University Of Nottingham Protein extraction, protein microarray and uses thereof
GB0900623D0 (en) 2009-01-15 2009-02-25 Cardiff & Vale Nhs Trust A method for diagnosing food allergy
US8450074B2 (en) * 2009-01-26 2013-05-28 W. Jean Dodds Multi-stage nutrigenomic diagnostic food sensitivity testing in animals
US20130183692A1 (en) * 2009-01-26 2013-07-18 W. Jean Dodds Intolerance testing for ingredients in nutrients, flavorings and therapeutics
US7892763B2 (en) * 2009-01-26 2011-02-22 Dodds W Jean Multi-stage nutrigenomic diagnostic food sensitivity testing in animals
CN102341705B (zh) * 2009-03-05 2015-08-19 味之素株式会社 克罗恩氏病诊断试剂
EP2529222A4 (en) * 2010-01-26 2013-10-09 Ridge Diagnostics Inc MULTIPLE BIOMARKER PANELS FOR STRATIFYING ILLNESS HEAVY GRADES AND MONITORING THE TREATMENT OF DEPRESSIONS
JP2011178679A (ja) 2010-02-26 2011-09-15 Kitasato Institute 和漢生薬由来多糖体を有効成分とする免疫調節剤及び飲食品
US20110318717A1 (en) 2010-06-23 2011-12-29 Laurent Adamowicz Personalized Food Identification and Nutrition Guidance System
US9292565B2 (en) 2010-06-30 2016-03-22 International Business Machines Corporation Template-based recognition of food product information
CN103430025B (zh) 2011-01-20 2017-12-26 西瑞斯实验室有限公司 检测谷蛋白敏感性和其区分于乳糜泻的方法和装置
US9053483B2 (en) 2011-09-30 2015-06-09 Microsoft Technology Licensing, Llc Personal audio/visual system providing allergy awareness
US20140322678A1 (en) 2013-04-24 2014-10-30 Kitchology Inc. Presentation of food information on a personal and selective dynamic basis and associated services
KR20130127145A (ko) 2012-05-14 2013-11-22 주식회사 푸른건강가족 복합 처방 서비스 시스템 및 방법
EP2850202B1 (en) 2012-05-18 2020-03-11 Genome Research Limited Methods and groups
ITVR20120176A1 (it) * 2012-09-04 2014-03-05 Univ Bologna Alma Mater Metodo e kit per la diagnosi ed il monitoraggio di sensibilita' ed intolleranze agli alimenti
JP2014079208A (ja) 2012-10-17 2014-05-08 Ryozo Saito 腸内環境及び腸管バリア改善サプリメント
EP2972371B1 (en) 2013-03-14 2018-09-05 Second Genome, Inc. Microbial ecology shift assay
WO2014182932A1 (en) 2013-05-08 2014-11-13 The Board Of Trustees Of The Leland Stanford Junior University Methods of testing for allergen sensitivity
US9212996B2 (en) 2013-08-05 2015-12-15 Tellspec, Inc. Analyzing and correlating spectra, identifying samples and their ingredients, and displaying related personalized information
HUP1300497A2 (en) 2013-08-23 2015-03-02 Janos Kuti Food supplement synergetic herbal composition and extract for decreasing the heavy metal contamination of human body, for the treatment of eczema, psoriasis, sun, food, metal or pollen allergy, for strengthen or balance the immune system, especially for the treatment of skin diseases or for increase the efficiency of the treatment of allergy
DE102013014080A1 (de) 2013-08-27 2015-03-05 Marco Mühle Informationssystem für Multi-Allergiker
EP3940380A1 (en) 2014-11-14 2022-01-19 Biomerica Inc. Compositions, devices, and methods of ibs sensitivity testing
WO2017015612A1 (en) 2015-07-22 2017-01-26 Biomerica, Inc. System and method for providing a food recommendation based on food sensitivity testing
CN108351356A (zh) 2015-09-09 2018-07-31 拜尔梅里科有限公司 骨关节炎敏感度测试的组合物、设备以及方法
MX2018007567A (es) 2015-12-21 2019-05-02 Biomerica Inc Composiciones, dispositivos y métodos de prueba de sensibilidad a los alimentos de personas con psoriasis.
JP2019501391A (ja) 2015-12-21 2019-01-17 バイオメリカ・インコーポレイテッドBiomerica, Inc. 片頭痛食物感受性試験のための組成物、装置、および方法
AU2017230706A1 (en) 2016-03-09 2018-09-27 Biomerica, Inc. Compositions, devices, and methods of functional dyspepsia sensitivity testing
EP3430403A4 (en) 2016-03-15 2019-08-14 Biomerica Inc. COMPOSITIONS, DEVICES AND METHODS FOR TESTING SENSITIVITY IN FIBROMYALGIA
CN109313186A (zh) 2016-04-26 2019-02-05 拜尔梅里科有限公司 克罗恩病敏感测试的组合物、设备以及方法
EP3449255B1 (en) 2016-04-26 2024-08-21 Biomerica, Inc. Compositions, devices, and methods of ulcerative colitis sensitivity testing
AU2017283493B2 (en) 2016-06-13 2022-12-22 Biomerica, Inc. Compositions, devices, and methods of gastroesophageal reflux disease sensitivity testing
JP6943479B2 (ja) 2016-07-08 2021-09-29 バイオメリカ・インコーポレイテッドBiomerica, Inc. うつ病感受性試験の組成物、デバイスおよび方法
WO2018009845A1 (en) 2016-07-08 2018-01-11 Biomerica, Inc. Compositions, devices, and methods of depression sensitivity testing
WO2018109746A1 (en) 2016-12-15 2018-06-21 Biomerica, Inc. Compositions, devices, and methods of attention deficit disorder/ attention deficit hyperactivity disorder (add/adhd) sensitivity testing

Also Published As

Publication number Publication date
JP7176791B2 (ja) 2022-11-22
US20190242904A1 (en) 2019-08-08
EP3497447B1 (en) 2024-09-04
US12216127B2 (en) 2025-02-04
EP3497447C0 (en) 2024-09-04
JP6943479B2 (ja) 2021-09-29
JP2019527823A (ja) 2019-10-03
JP2022190090A (ja) 2022-12-22
EP3497447A1 (en) 2019-06-19
EP3497447A4 (en) 2020-01-22
CN109804247A (zh) 2019-05-24
JP2021192047A (ja) 2021-12-16

Similar Documents

Publication Publication Date Title
MX2021009297A (es) Composiciones, dispositivos, y metodos de pruebas de sensibilidad del ibs.
MX2023005293A (es) Composiciones, dispositivos y metodos de prueba de sensibilidad a la depresion.
BR112017007965A2 (pt) método implantado por computador para inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; aparelho para inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; meio de armazenamento não transitório; programa de computador; kits para medir níveis de expressão de três ou mais genes-alvo da via de sinalização celular de tgf-b em uma amostra de um indivíduo; inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; e uso do kit
SG11201900126YA (en) Object selection method and apparatus
MY189778A (en) Method for producing retinal pigment epithelial cells
CA2961701C (en) Method and system for determining the local quality of surface data extracted from volume data
MX2013013866A (es) Sistema y metodo para prueba y optimizacion de precios.
MX2022013625A (es) Metodo para evaluar los efectos de una composicion que comprende microorganismos en la microbiota intestinal.
MX2023006660A (es) Composiciones, dispositivos, y metodos de pruebas de sensibilidad a la osteoartritis.
WO2015160415A3 (en) Systems and methods for visual sentiment analysis
MX2018011166A (es) Composiciones, dispositivos y metodos de prueba de sensibilidad de fibromialgia.
MX2022000425A (es) Metodos y composiciones que comprenden un nivel reducido de proteinas de celulas hospedadoras.
MX2018007567A (es) Composiciones, dispositivos y métodos de prueba de sensibilidad a los alimentos de personas con psoriasis.
GB2542576A (en) Method and kit of detecting the absence of micro-oranisms
NZ730124A (en) A method of predicting risk of recurrence of cancer
MX2024000466A (es) Composiciones, dispositivos y metodos de pruebas de sensibilidad a la enfermedad de crohn.
EP4389904A3 (en) Microorganisms for producing 4c-5c compounds with unsaturation and methods related thereto
MY187907A (en) Methods and snp detection kits for predicting palm oil yield of a test oil palm plant
MX2018010856A (es) Composiciones, dispositivos y metodos de pruebas de sensibilidad de dispepsia funcional.
MX2018015334A (es) Composiciones, dispositivos y métodos de prueba de sensibilidad a los alimentos a la enfermedad de reflujo gastroesofageal.
MX2018013120A (es) Composiciones, dispositivos y metodos de prueba de sensibilidad a la colitis ulcerosa.
MX391844B (es) Metodo y aparato para estimar la cantidad de microorganismos en una unidad taxonomica en una muestra.
MX2023005604A (es) Composiciones, dispositivos, y metodos de prueba de sensibilidad para el trastorno de deficit de atencion/trastorno de hiperactividad con deficit de atencion (add/adhd).
MX2018007566A (es) Composiciones, dispositivos y métodos de prueba de sensibilidad a los alimentos de personas con dolor de cabeza por migraña.
MX2019000143A (es) Composiciones, dispositivos y métodos de prueba de sensibilidad a la depresión.